Sandu Pharmaceuticals informs about quarterly statement on investor complaints

13 Jul 2016 Evaluate

Sandu Pharmaceuticals has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Sandu Pharmaceutical Share Price

37.90 0.47 (1.26%)
01-Jan-2026 09:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1713.90
Dr. Reddys Lab 1252.85
Cipla 1502.95
Zydus Lifesciences 910.75
Lupin 2096.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×